Who should have access to emerging technologies that change or alter memories?
The Patient Protection and Affordable Care Act of 2010 (ACA) prevents insurer discrimination on the basis of "preexisting conditions." Does predictive neuroscience information about a condition like Alzheimer’s disease (AD), gathered before the onset of any symptoms, constitute a "preexisting condition"?
For an analysis of these and other ethical considerations relevant to new innovations in neuropsychology, see the December 2016 issue of the AMA Journal of Ethics.
From the Editor
In the Literature
State of the Art and Science
The Legal Implications of Detecting Alzheimer’s Disease Earlier
Medicine and Society
Images of Healing and Learning
© 2016 American Medical Association. All Rights Reserved. ISSN 2376-6980